Image de couverture de livre

Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Milla Laine, Jani Raitanen, Anssi Auvinen
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	European Journal of Neurology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Monoclonal Gammopathy in Amyotrophic Lateral Sclerosis: No Impact on Clinical Progression and Immunotherapy Outcomes
par: Hyunkee Kim, et autres
Publié: (2025)

Transcranial Brain Parenchyma Sonographic Findings in Familial and Sporadic Amyotrophic Lateral Sclerosis
par: Ivo Bozovic, et autres
Publié: (2025)

Reappraisal of the Diagnostic Significance of Transcranial Magnetic Stimulation and Triple Stimulation in Amyotrophic Lateral Sclerosis
par: Birgit Andersen, et autres
Publié: (2026)

Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters
par: Jie Yang, et autres
Publié: (2025)

Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis
par: Alessandro Bombaci, et autres
Publié: (2025)

Population‐Based Versus Hospital‐Based Data in Amyotrophic Lateral Sclerosis—A Factor to Consider?
par: Johannes Dorst, et autres
Publié: (2025)

Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis
par: Cailin He, et autres
Publié: (2026)

Progressive Thalamo‐Cortical Disconnection in Amyotrophic Lateral Sclerosis Genotypes: Structural Degeneration and Network Dysfunction of Thalamus‐Relayed Circuits
par: Marlene Tahedl, et autres
Publié: (2025)

Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States
par: Narghes Calcagno, et autres
Publié: (2025)

Diagnostic and Prognostic Value of Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta‐Analysis
par: Kazuki Obara, et autres
Publié: (2025)

MEPs and MRI Motor Band Sign as Potential Complementary Markers of Upper Motor Neuron Involvement in Amyotrophic Lateral Sclerosis
par: Francesca Calvi, et autres
Publié: (2025)

Greek Registry for Amyotrophic Lateral Sclerosis (ALS‐GR): An Observational Cohort of Individuals With ALS Across 11 Specialized Centers in Greece
par: Ioannis Liampas, et autres
Publié: (2025)

Association of Reduced Brain Metabolism With Motor Function and Survival in Amyotrophic Lateral Sclerosis Patients With Neurofilament Heavy (NEFH) Gene Mutation
par: Xinyu Song, et autres
Publié: (2025)

De‐Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in Austria
par: Michael Guger, et autres
Publié: (2025)

Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample
par: Anne Kever, et autres
Publié: (2025)

Erythrocyte Fragility in Progressive Multiple Sclerosis
par: Carmen Jacob, et autres
Publié: (2026)

Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage
par: Simón Cárdenas‐Robledo, et autres
Publié: (2025)

Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis
par: Nahid Moradi, et autres
Publié: (2026)

Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis
par: Ferdinando Clarelli, et autres
Publié: (2025)

The Effects of Disease‐Modifying Therapies on Optic Nerve Degeneration in Multiple Sclerosis
par: Xia Zhang, et autres
Publié: (2025)

Jaw Clonus in Amyotrophic Lateral Sclerosis
par: Ryuichi Inoue, et autres
Publié: (2026)

A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis
par: Camilla Maersk‐Moller, et autres
Publié: (2026)

Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?
par: Nima Mahmoudi, et autres
Publié: (2026)

Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study
par: Chloe Pierret, et autres
Publié: (2025)

Sex and Gender Transition of People With Multiple Sclerosis: A Real‐World Perspective
par: Pasquale Paletta, et autres
Publié: (2025)

The Variant rs7665090 Is Associated With Interferon‐Beta Response in Multiple Sclerosis Patients
par: Andreu Vilaseca, et autres
Publié: (2025)

Confirmed Worsening of Health‐Related Quality of Life to Monitor Long‐Term MS Disease Progression: A Longitudinal Analysis From the Swiss Multiple Sclerosis Registry
par: Stefania Iaquinto, et autres
Publié: (2025)

Optimized Kappa‐Index Test Protocol to Detect Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis
par: Joel Björklund, et autres
Publié: (2025)

MOG‐IgG Frequency in Multiple Sclerosis: Diagnostic Challenges With Low‐Titer Results
par: Jae‐Won Hyun, et autres
Publié: (2025)

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis
par: Nicolás Fissolo, et autres
Publié: (2026)

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study
par: Anne Høgset, et autres
Publié: (2026)

De‐Escalation of Disease‐Modifying Therapy in Multiple Sclerosis—A Danish Nationwide Cohort Study
par: Frederik Elberling, et autres
Publié: (2025)

Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis
par: Theodoros Ladopoulos, et autres
Publié: (2025)

Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population‐based registry study
par: Fredrik Piehl, et autres
Publié: (2024)

Assessing Optic Nerve Involvement in Multiple Sclerosis Using Optical Coherence Tomography and Magnetic Resonance Imaging
par: Gualco Alessandro, et autres
Publié: (2026)

Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis
par: Igal Rosenstein, et autres
Publié: (2026)

Reasons for Healthcare Use Before Onset of Multiple Sclerosis: A Nationwide Matched Cohort Study in Sweden
par: Ali Manouchehrinia, et autres
Publié: (2025)

The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Regression‐based norms for German‐speaking countries
par: I. K. Penner, et autres
Publié: (2025)

Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical Implications
par: Alessandra Cicia, et autres
Publié: (2026)

Stratifying Multiple Sclerosis Susceptibility Risk: The Role of HLA‐E*01 and Infectious Mononucleosis in a Population Cohort
par: Andrea Nova, et autres
Publié: (2025)